GASTROINTESTINAL NEUROENDOCRINE TUMORS

Clinical trials for GASTROINTESTINAL NEUROENDOCRINE TUMORS explained in plain language.

Never miss a new study

Get alerted when new GASTROINTESTINAL NEUROENDOCRINE TUMORS trials appear

Sign up with your email to follow new studies for GASTROINTESTINAL NEUROENDOCRINE TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Completed 1

New drug tested for Tough-to-Treat stomach and intestinal cancers

Disease control Completed

This first-in-human study tested a new drug called Cabotamig in 33 adults with advanced gastrointestinal cancers that had stopped responding to standard treatments. The main goals were to check the drug's safety, see how the body processes it, and look for early signs that it mig…

Matched conditions: GASTROINTESTINAL NEUROENDOCRINE TUMORS

Phase: PHASE1 • Sponsor: Arbele Pty Ltd • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC

GASTROINTESTINAL NEUROENDOCRINE TUMORS

Get alerted when new GASTROINTESTINAL NEUROENDOCRINE TUMORS trials appear

New drug tested for Tough-to-Treat stomach and intestinal cancers